AMPK beta2 activators (Nimbus Therapeutics)

N/A

Report date: 2025/03/18 18:03:40
NME

Base Information

Drug NameAMPK beta2 activators (Nimbus Therapeutics)
Drug Alias NameAMP activated protein kinasebeta2 activators (Nimbus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNimbus Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesNimbus Therapeutics LLCEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A